Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient’s quality of life

Authors

  • I. Alobid,

    1. Rhinology Unit and Smell Clinic, Department of Otorhinolaryngology, Hospital Clínic i Universitari
    2. Department of Otorhinolaryngology, Hospital Municipal de Badalona
    Search for more papers by this author
  • M. Bernal-Sprekelsen,

    1. Rhinology Unit and Smell Clinic, Department of Otorhinolaryngology, Hospital Clínic i Universitari
    Search for more papers by this author
  • J. Mullol

    1. Rhinology Unit and Smell Clinic, Department of Otorhinolaryngology, Hospital Clínic i Universitari
    2. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    Search for more papers by this author

J. Mullol
Rhinology Unit and Smell Clinic
Department of Otorhinolaryngology
Hospital Clínic i Universitari
c/Villarroel, 170
Barcelona 08036
Spain

Abstract

Chronic rhinosinusitis (CRS) including nasal polyps is a chronic inflammatory disease of the nasal and paranasal sinus mucosa that, despite differing hypotheses of its cause, remains poorly understood. Primary symptoms are nasal blockage, loss of smell, rhinorrhea, and facial pain or pressure. Chronic rhinosinusitis causes significant physical symptoms, has a negative impact on quality of life (QoL), and can substantially impair daily functioning. A global evaluation of patients must include, together with nasal symptoms, nasal endoscopy, and CT scan, the measurement of QoL. To assess QoL in CRS, specific and generic questionnaires may be used. Chronic rhinosinusitis has a considerable impact on a patient’s QoL but comorbidities, such as asthma and atopy, have an accumulative negative effect. Both medical and surgical treatments lead to a similar improvement on the QoL of CRS and nasal polyp patients.

Ancillary